Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies
出版年份 2017 全文链接
标题
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies
作者
关键词
-
出版物
Nature Reviews Endocrinology
Volume 13, Issue 11, Pages 644-660
出版商
Springer Nature
发表日期
2017-07-14
DOI
10.1038/nrendo.2017.76
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2017) Betty R. Ferrell et al. JOURNAL OF CLINICAL ONCOLOGY
- Lenvatinib for Anaplastic Thyroid Cancer
- (2017) Makoto Tahara et al. Frontiers in Oncology
- 995PDPHASE II STUDY OF LENVATINIB (LEN), A MULTI-TARGETED TYROSINE KINASE INHIBITOR, IN PATIENTS (PTS) WITH ALL HISTOLOGIC SUBTYPES OF ADVANCED THYROID CANCER (DIFFERENTIATED, MEDULLARY AND ANAPLASTIC)
- (2017) S. Takahashi et al. ANNALS OF ONCOLOGY
- Lenvatinib: Role in thyroid cancer and other solid tumors
- (2016) Maria E. Cabanillas et al. CANCER TREATMENT REVIEWS
- Anaplastic thyroid cancer: Prognostic factors, patterns of care, and overall survival
- (2016) Scott M. Glaser et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Association Between Palliative Care and Patient and Caregiver Outcomes
- (2016) Dio Kavalieratos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer
- (2016) Jill J. Bastman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
- (2016) Iñigo Landa et al. JOURNAL OF CLINICAL INVESTIGATION
- A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma
- (2016) Cristina Romei et al. Nature Reviews Endocrinology
- Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
- (2016) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- Erratum: Specific microRNAs are downregulated in human thyroid anaplastic carcinomas
- (2016) R Visone et al. ONCOGENE
- Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in aBRAFV600EMutation-Prevalent Area
- (2016) Min Ji Jeon et al. THYROID
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
- (2016) Bryan R. Haugen et al. THYROID
- Impact of Timeliness of Resection and Thyroidectomy Margin Status on Survival for Patients with Anaplastic Thyroid Cancer: An Analysis of 335 Cases
- (2015) Paolo Goffredo et al. ANNALS OF SURGICAL ONCOLOGY
- Use of vemurafenib in anaplastic thyroid carcinoma: a case report
- (2015) Kristen A Marten et al. CANCER BIOLOGY & THERAPY
- Lung adenocarcinoma and its thyroid metastasis characterized on fine-needle aspirates by cytomorphology, immunocytochemistry, and next-generation sequencing
- (2015) Claudio Bellevicine et al. DIAGNOSTIC CYTOPATHOLOGY
- Phase 2 clinical trial of sunitinib as adjunctive treatment in patients with advanced differentiated thyroid cancer
- (2015) Athanasios Bikas et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing
- (2015) John W. Kunstman et al. HUMAN MOLECULAR GENETICS
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
- (2015) Martin Schlumberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Tumor Shrinkage Under Treatment with First-line Tyrosine Kinase Inhibitors as a Predictor of Overall Survival in Patients with Metastatic Renal Cell Carcinoma: a Retrospective Multi-Institutional Study in Japan
- (2015) Hideaki Miyake et al. Targeted Oncology
- Survival After Renal Cell Carcinoma Metastasis to the Thyroid: Single Center Experience and Systematic Review of the Literature
- (2015) Ulrich Beutner et al. THYROID
- Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma
- (2015) Yuval Nachalon et al. JAMA Otolaryngology-Head & Neck Surgery
- Integrated Genomic Characterization of Papillary Thyroid Carcinoma
- (2014) Nishant Agrawal et al. CELL
- Cell Cycle Deregulation andTP53andRASMutations Are Major Events in Poorly Differentiated and Undifferentiated Thyroid Carcinomas
- (2014) Jaime Miguel Pita et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas
- (2014) Miguel Melo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Activating BRAF and PIK3CA Mutations Cooperate to Promote Anaplastic Thyroid Carcinogenesis
- (2014) Roch-Philippe Charles et al. MOLECULAR CANCER RESEARCH
- Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer
- (2014) Nikhil Wagle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of a Recurrent STRN/ALK Fusion in Thyroid Carcinomas
- (2014) Gaëlle Pérot et al. PLoS One
- Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer
- (2014) L. M. Kelly et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology
- (2014) Cesar Seigi Fuziwara et al. International Journal of Endocrinology
- A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes
- (2013) S. M. Lim et al. ANNALS OF ONCOLOGY
- Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial
- (2013) R. C. Smallridge et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1
- (2013) Teresa Di Desidero et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- ATP-competitive inhibitors block protein kinase recruitment to the Hsp90-Cdc37 system
- (2013) Sigrun Polier et al. Nature Chemical Biology
- BRAF V600E Inhibition in Anaplastic Thyroid Cancer
- (2013) Michael H. Rosove et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pazopanib Enhances Paclitaxel-Induced Mitotic Catastrophe in Anaplastic Thyroid Cancer
- (2013) C. R. Isham et al. Science Translational Medicine
- Randomized Safety and Efficacy Study of Fosbretabulin with Paclitaxel/Carboplatin Against Anaplastic Thyroid Carcinoma
- (2013) Julie A. Sosa et al. THYROID
- Sorafenib in metastatic thyroid cancer
- (2012) Jaume Capdevila et al. ENDOCRINE-RELATED CANCER
- A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer
- (2012) Keith C. Bible et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pazopanib alone is not effective against anaplastic thyroid cancer
- (2012) Andy McLarnon Nature Reviews Endocrinology
- American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
- (2012) Robert C. Smallridge et al. THYROID
- Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid
- (2012) Panayiotis Savvides et al. THYROID
- E7080, a multi-targeted tyrosine kinase inhibitor suppresses tumor cell migration and invasion
- (2011) Hilary Glen et al. BMC CANCER
- Anaplastic Thyroid Cancers Harbor Novel Oncogenic Mutations of the ALK Gene
- (2011) A. K. Murugan et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint
- (2011) Vincenzo Marotta et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs
- (2011) Chun-Ju Chang et al. NATURE CELL BIOLOGY
- Tumor-Associated Macrophages (TAMs) Form an Interconnected Cellular Supportive Network in Anaplastic Thyroid Carcinoma
- (2011) Bernard Caillou et al. PLoS One
- Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer
- (2010) Avaniyapuram Kannan Murugan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Anaplastic Thyroid Carcinoma: Pathogenesis and Emerging Therapies
- (2010) R.C. Smallridge et al. CLINICAL ONCOLOGY
- An Evaluation of the Drug Interaction Potential of Pazopanib, an Oral Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, Using a Modified Cooperstown 5+1 Cocktail in Patients With Advanced Solid Tumors
- (2010) B C Goh et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Identification of several novel non-p.R132 IDH1 variants in thyroid carcinomas
- (2010) Jefferson Pessoa Hemerly et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas
- (2010) J Braun et al. ONCOGENE
- A Phase II Study of Imatinib in Patients with Advanced Anaplastic Thyroid Cancer
- (2010) Huan T. Ha et al. THYROID
- Enhanced Survival in Locoregionally Confined Anaplastic Thyroid Carcinoma: A Single-Institution Experience Using Aggressive Multimodal Therapy
- (2010) Robert L. Foote et al. THYROID
- Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
- (2009) Kristy J. Gotink et al. ANGIOGENESIS
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for BRAF, PIK3CA, and AKT1
- (2009) J. C. Ricarte-Filho et al. CANCER RESEARCH
- Gastrointestinal Stromal Tumor: A Clinical Overview
- (2009) Richard Quek et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
- (2009) Richard T. Kloos et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase II Trial of Fosbretabulin in Advanced Anaplastic Thyroid Carcinoma and Correlation of Baseline Serum-Soluble Intracellular Adhesion Molecule-1 with Outcome
- (2009) Colin J. Mooney et al. THYROID
- Molecular Diagnostics and Predictors in Thyroid Cancer
- (2009) Marina N. Nikiforova et al. THYROID
- Induction Chemotherapy with Weekly Paclitaxel Administration for Anaplastic Thyroid Carcinoma
- (2009) Takuya Higashiyama et al. THYROID
- Gastrointestinal stromal tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
- (2008) P. G. Casali et al. ANNALS OF ONCOLOGY
- Treatment Outcomes in Anaplastic Thyroid Carcinoma: Survival Improvement in Young Patients With Localized Disease Treated by Combination of Surgery and Radiotherapy
- (2008) Thomas Yau et al. ANNALS OF SURGICAL ONCOLOGY
- International patterns and trends in thyroid cancer incidence, 1973–2002
- (2008) Briseis A. Kilfoy et al. CANCER CAUSES & CONTROL
- Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells
- (2008) Shu Takakura et al. CANCER SCIENCE
- Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer
- (2008) M. Ryder et al. ENDOCRINE-RELATED CANCER
- Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
- (2008) Robert C Smallridge et al. ENDOCRINE-RELATED CANCER
- MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic Utility
- (2008) Marina N. Nikiforova et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Highly Prevalent Genetic Alterations in Receptor Tyrosine Kinases and Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase Pathways in Anaplastic and Follicular Thyroid Cancers
- (2008) Zhi Liu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study
- (2008) Ezra E.W. Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Sorafenib in Advanced Thyroid Cancer
- (2008) Vandana Gupta-Abramson et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase II Study of Gefitinib in Patients with Advanced Thyroid Cancer
- (2007) Nathan A. Pennell et al. THYROID
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started